Bupropion Hydrochloride Tablet, Extended Release
Product Images NDC 47335-954

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 47335-954). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Spl-bupropion-chemical-structure (Spl Bupropion Chemical Structure)

Chemical structure of Bupropion Hydrochloride showing a chlorophenyl group bonded to a ketone and a tert-butylamino group, with hydrochloride (HCl) indicated as part of the compound.*

FDA Label Image

Spl-bupropion-label-150mg (Spl Bupropion Label 150mg)

Label for Bupropion Hydrochloride Extended-release Tablets USP (XL) 150 mg by Sun Pharmaceutical Industries, Inc. The label indicates oral extended-release tablets, 30 count, with dosage instructions for once daily use. It includes storage conditions, warnings against use with Zyban or similar products, and manufacturer details from Sun Pharmaceutical Industries Limited in India.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.